Signatures of tumor–immune interactions as biomarkers for breast cancer prognosis

Author： Manjili Masoud H   Najarian Kayvan   Wang Xiang-Yang  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.6, 2012-06, pp. : 703-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Signatures Predict Prognosis in Localized Cancer

By Hsu David S   Kim Mickey K   Balakumaran Bala S.   Acharya Chaitanya R   Anders Carey K   Clay Tim   Lyerly H. Kim   Drake Charles G.   Morse Michael A.   Febbo Phillip G.  

Cancer Investigation, Vol. 28, Iss. 7, 2010-07 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite

Pro-metastatic tumor–stroma interactions in breast cancer

By Gangadhara Sharath   Barrett-Lee Peter   Nicholson Robert I   Hiscox Stephen  

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1427-1442

Future Medicine

Access to resources Recommend Favorite

Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis

By Saloustros Emmanouil   Mavroudis Dimitris  

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 209-219

Future Medicine

Access to resources Recommend Favorite

Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: New primary cancer allows a good prognosis

By Nishimura Seiichiro  

Breast Cancer, Vol. 12, Iss. 2, 2005-04 ,pp. : 112-117

Springer Publishing Company

Access to resources Recommend Favorite

Emerging Breast Cancer Biomarkers

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-01 ,pp. : 79-85

Bentham Science Publishers

Access to resources Recommend Favorite